Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management: Response to ‘No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report’

مواد مشابهة

• Sentinel-Node Biopsy in Melanoma
  بواسطة: Thompson, John F., وآخرون
  منشور في: (2014)
• Sentinel Node Biopsy for Early-Stage Melanoma: Accuracy and Morbidity in MSLT-I, an International Multicenter Trial
  بواسطة: Morton, Donald L., وآخرون
  منشور في: (2005)
• Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
  بواسطة: Morton, D.L., وآخرون
  منشور في: (2014)
• The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I)
  بواسطة: Faries, Mark B., وآخرون
  منشور في: (2010)
• Sentinel Lymph Node Biopsy for Melanoma: A Plea to Let the Data be Heard
  بواسطة: Thompson, John F., وآخرون
  منشور في: (2014)